Basic information Application Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridazine compounds >  8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE

8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE

Basic information Application Safety Supplier Related

8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE Basic information

Product Name:
8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE
Synonyms:
  • 8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE
  • IMidazo[1,2-b]pyridazine, 8-broMo-6-chloro-
  • 8-broMo-6-chloroiMidazo[1
  • 8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE ISO 9001:2015 REACH
CAS:
933190-51-3
MF:
C6H3BrClN3
MW:
232.47
Mol File:
933190-51-3.mol
More
Less

8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE Chemical Properties

Density 
2.03±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
0.73±0.30(Predicted)
Appearance
Light yellow to brown Solid
InChI
InChI=1S/C6H3BrClN3/c7-4-3-5(8)10-11-2-1-9-6(4)11/h1-3H
InChIKey
LZEJQXOCRMRVNP-UHFFFAOYSA-N
SMILES
C12=NC=CN1N=C(Cl)C=C2Br
More
Less

8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE Usage And Synthesis

Application

8-Bromo-6-chloroimidazole[1,2-B]pyridazine is a pyridazine organic compound that can be used as a pharmaceutical intermediate.

Synthesis

446273-59-2

621-62-5

933190-51-3

3-Amino-4-bromo-6-chloropyridazine (15.7 g, 75.3 mmol) and chloroacetaldehyde diethyl acetal (13.9 g, 90.3 mmol) were reacted in isopropanol (150 mL) in the presence of p-toluenesulfonic acid (PTSA, 17.2 g, 90.3 mmol). The reaction mixture was heated to 80 °C and maintained at this temperature for 20 hours. Upon completion of the reaction, the mixture was cooled to room temperature and subsequently concentrated under reduced pressure to remove the solvent. The concentrated residue was neutralized with saturated sodium bicarbonate solution (300 mL) and then extracted with dichloromethane (200 mL × 3). The organic layers were combined, dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (200-300 mesh, petroleum ether:ethyl acetate = 3:1) to afford the target product, 8-bromo-6-chloroimidazo[1,2-b]pyridazine (17.2 g, 98% yield), as an orange solid.LC-MS analysis showed [M + H]+ m/z 231.9, 233.9, and retention time tR = 1.46 min.

References

[1] Journal of Medicinal Chemistry, 2012, vol. 55, # 23, p. 10414 - 10423
[2] Patent: US2013/109661, 2013, A1. Location in patent: Paragraph 0227-0228
[3] Patent: WO2013/64445, 2013, A1. Location in patent: Page/Page column 51

8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINESupplier

Shanghai Bank Pharma Limited Gold
Tel
021-2221346380 021-54220652 17701603001
Email
bankpharma@163.com
Shanghai Hongle Biotechnology Co., Ltd Gold
Tel
021-56145923; 4001631568
Email
sales@honglebiotech.com
Shanghai Dingshi Pharmaceutical Technology Co., Ltd Gold
Tel
15921634331
Email
1509836518@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
More
Less

8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE(933190-51-3)Related Product Information